Green light for human trial is already assured from the pre-IND mtg w/ the FDA where we met/fulfilled their questions and now are ready/ have already submitted a new IND this week. FDA and IPIX now on same page as to trial protocol and all matters relating to such trial.
So a human trial announcement shouldn't do much. Even interim data may not do much but once we get interim data from Euro trial that should show us whether the USA trial will be a success or not and that should pull some people's heads up for some air and the share price to rise. If interim data real good, we are as good as gold IMO.
News 
Market Data 
Discover 
